Research review
TB-500 vs thymosin beta-4: what the research actually shows
17 September 2026 · 6 min read
Thymosin beta-4 (Tβ4) and TB-500 are two names that people in the research peptide community often use as if they meant the same thing. They do not. Thymosin beta-4 is a well-characterised, naturally occurring peptide, while TB-500 is a trade name under which several synthetic products are sold. This guide separates the two, summarises what has been observed in research, and explains what to check before you buy a research reagent.
What thymosin beta-4 is
Thymosin beta-4 is a peptide made of 43 amino acid residues. It belongs to the thymosin family, named after the thymus gland, where these peptides were first isolated. Researchers have described it in many cell types, and its presence has been linked to platelets and to tissues involved in repair processes.
For a laboratory this matters. The sequence, the known functions and the analytical methods for Tβ4 are widely documented, so it is easier to judge whether a product matches what the literature describes.
TB-500 vs thymosin beta-4: what overlaps and what does not
TB-500 is not a single, strictly defined substance. Depending on the supplier, it is described as a fragment of thymosin beta-4 covering the active region, or it is sold as the full sequence. The same label therefore does not guarantee an identical compound.
| Feature | Thymosin beta-4 (Tβ4) | TB-500 (research reagent) |
|---|---|---|
| Length | 43 amino acid residues | Varies by supplier: a fragment or the full sequence |
| Active region | LKKTETQ motif in the N-terminal part | Often described as covering the same region |
| What to verify | Sequence and molecular mass | Sequence, mass (MS) and purity (HPLC) |
The practical rule is simple: before you buy, check the declared sequence, mass and purity. Only then do you know what is actually in the vial.
G-actin binding and the LKKTETQ motif
The most frequently described biochemical function of Tβ4 is binding to monomeric actin, known as G-actin. Actin forms filaments that build the cell’s cytoskeleton. Tβ4 binds G-actin and influences the balance between monomers and filaments, which in turn affects cell shape and movement.
The binding site reported in the literature is the LKKTETQ sequence in the N-terminal part of the molecule. A short motif like this is a convenient model for in vitro work, since it is easier to synthesise and analyse than the whole protein. If a reagent contains this fragment, it can be linked to the actin-binding properties described in published studies.
Cell migration in vitro
In cell cultures, Tβ4 has been observed to affect cell migration, including endothelial cells and keratinocytes. Standard tools for this are the scratch assay, which tracks how quickly cells close a gap in a monolayer, and transwell migration assays, which measure how cells move toward a signal.
Results depend on conditions: cell type, medium composition, reagent concentration and incubation time. Reliable publications therefore describe their controls and replicates in detail. In your own experiments, record the batch number so that results can be reproduced and compared.
Angiogenesis in models
Angiogenesis, the formation of new blood vessels from existing ones, is another area where Tβ4 has been studied. In animal models, researchers have described the peptide’s involvement in vessel-related processes, and in vitro work has observed effects on the migration and organisation of endothelial cells.
Angiogenesis models are simplifications of what happens in a living system. A tube-formation assay on extracellular matrix captures one aspect of the process, not the whole process. For that reason, such results are treated as preliminary and need further verification.
The Ac-SDKP and LKKTETQ fragments: two different routes
Two fragments that are often confused with each other come from the same parent molecule. They have different structures and are used to answer different research questions.
Ac-SDKP is an acetylated tetrapeptide, a short chain of four amino acids: serine, aspartic acid, lysine and proline, with an acetyl group at the start of the chain. It is known to be broken down by angiotensin-converting enzyme (ACE), which makes it an important subject in research on cardiovascular regulation. Preclinical studies have described its involvement in fibrosis, the build-up of connective tissue.
LKKTETQ is a separate seven-residue motif, the one discussed above in the context of G-actin binding. Both fragments come from the same molecule but serve different questions. When you choose a reagent, always check which sequence and which region are in the product.
What preclinical research shows
Thymosin beta-4 has been the subject of many preclinical studies. It has also been tested clinically as a topical preparation, including in wound-healing and ocular surface research. Those findings come from specific trials run under specific conditions, and they do not transfer automatically to every fragment or to every product sold under the name TB-500.
For a researcher, the takeaway is that mechanisms described in vitro and in animal models are a starting point for designing an experiment, not a finished answer. A research reagent should be selected on the basis of its verified purity and identity, not on its name alone.
Laboratory practice: what to watch
Careful handling of lyophilised material decides whether your results are reliable. The essentials:
- Reconstitution: use the solvent and procedure given on the product sheet, work aseptically and record the date the solution was prepared.
- Storage: keep the lyophilised powder tightly closed, away from moisture and light, at the temperature stated on the product sheet.
- Purity check: compare HPLC and MS results for your batch before you start the actual study.
- Documentation: note the batch number for every experiment so you can trace the source of any result.
How to recognise a good research reagent
| Detail | Why it matters |
|---|---|
| Sequence | Confirms which peptide or fragment is contained |
| Mass (MS) | Confirms the identity of the compound |
| Purity (HPLC) | Shows the share of the target peptide, at least 99% in our batches |
Shipping and payment
| Destination | Shipping method | Delivery time | Shipping cost |
|---|---|---|---|
| Poland | InPost Paczkomat | next business day | free from 75 EUR (300 zł in Poland) |
| Europe (29 countries) | DPD courier | 2-4 business days | free from 75 EUR |
Orders placed by 14:00 on a business day ship the same day. Pay online by card, Apple Pay, Google Pay or BLIK (PLN only). Available currencies are PLN, EUR, GBP and USD.
Key takeaways
- TB-500 is a trade name, so always verify the sequence and mass.
- Thymosin beta-4 has 43 amino acid residues, and the LKKTETQ motif is described as the G-actin binding region.
- In vitro work has observed effects on cell migration, and animal models have described involvement in angiogenesis.
- Ac-SDKP is a separate, short tetrapeptide broken down by ACE and studied in the context of fibrosis.
- All results discussed here come from preclinical research and depend on the model and conditions.
- Our reagents are sold for research use only, with purity of 99% or higher confirmed by HPLC and mass confirmed by MS.
Explore TB-500 in the shop and BPC-157 with TB-500. We describe our testing standards on our quality page, and you can run your concentration calculations in the concentration calculator.